69 results
F-1
AMYT
Amryt Pharma Plc
23 Jun 20
Registration statement (foreign)
5:21pm
States under the trade name JUXTAPID and in the European Union under the trade name LOJUXTA. HoFH is a rare and serious genetic condition that leads … in the European Union under the trade name MYALEPTA for the treatment of leptin deficiency in patients with congenital or acquired GL and familial or acquired PL
F-1/A
AMYT
Amryt Pharma Plc
6 Jul 20
Registration statement (foreign) (amended)
5:28pm
with HoFH. It is marketed in the United States under the trade name JUXTAPID and in the European Union under the trade name LOJUXTA. HoFH is a rare … or acquired GL. It is approved in the European Union under the trade name MYALEPTA for the treatment of leptin deficiency in patients with congenital
424B4
AMYT
Amryt Pharma Plc
8 Jul 20
Prospectus supplement with pricing info
4:05pm
the trade name JUXTAPID and in the European Union under the trade name LOJUXTA. HoFH is a rare and serious genetic condition that leads to aggressive … as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired GL. It is approved in the European Union under
DRS/A
AMYT
Amryt Pharma Plc
29 May 20
Draft registration statement (amended)
12:00am
States under the trade name JUXTAPID and in the European Union under the trade name LOJUXTA. HoFH is a rare and serious genetic condition that leads … in the European Union under the trade name MYALEPTA for the treatment of leptin deficiency in patients with congenital or acquired GL and familial or acquired PL
F-1
AMYT
Amryt Pharma Plc
8 Jan 21
Registration statement (foreign)
4:58pm
and other lipid-lowering treatments for adults with HoFH. It is marketed in the United States under the trade name JUXTAPID and in the European Union … the complications of leptin deficiency in patients with congenital or acquired GL. It is approved in the European Union under the trade name MYALEPTA
424B4
i3e6pu9ywozr0wmgpxc5
14 Jan 21
Prospectus supplement with pricing info
9:30am
DRS
uvm0e74gszl0d1etz
18 Dec 20
Draft registration statement
12:00am
F-1/A
u09sqfhw9r83lm9g
12 Jan 21
Registration statement (foreign) (amended)
12:00am
20-F
dijfkv9
30 Apr 21
Annual report (foreign)
12:53pm
DRS
9eq10
19 Feb 20
Draft registration statement
12:00am
6-K
EX-99.2
w1tkv75x
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.2
vg0hq
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
6-K
EX-99.3
lz5qy38o 5sk
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
6-K
EX-99.2
dfja 7um4uyda
11 May 22
Current report (foreign)
4:30pm
6-K
EX-99.3
ogi35gfmbfwx
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.1
3j3p3ak9ivt7ag
1 Jun 22
Current report (foreign)
6:05am
6-K
EX-99.4
67mbr4rwy
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.2
ii832ijn1 mniz9
1 Jun 22
Current report (foreign)
6:05am
6-K
EX-99.1
4nx80k8zr0r
3 Nov 22
Current report (foreign)
7:44am